Peer-Reviewed Journal Details
Mandatory Fields
Larose, Eric and Cote, Julie and Rodes-Cabau, Josep and Noel, Bernard and Barbeau, Gerald and Bordeleau, Edith and Miro, Santiago and Brochu, Bernard and Delarochelliere, Robert and Bertrand, Olivier F.;
2009
Unknown
International Journal of Cardiovascular Imaging
Contrast-enhanced cardiovascular magnetic resonance in the hyperacute phase of ST-elevation myocardial infarction
Validated
()
Optional Fields
25
5
519
527

Cardiovascular magnetic resonance (CMR) very early after primary percutaneous coronary intervention (PPCI) may lead to instability or early stent complications. However, CMR in the hyperacute phase of STEMI may improve risk stratification. We investigated feasibility and safety of CMR in the hyperacute phase of STEMI immediately after PPCI. One hundred and twenty eight consecutive patients immediately after PPCI for STEMI. Sixty four underwent CMR < 12 h after PPCI versus 64 matched controls. Outcomes were followed over 6 months. CMR in hyperacute STEMI was not associated with in-hospital death, infarct expansion, or urgent revascularization (P=NS). CMR (32 ml gadolinium contrast) immediately after PPCI (180 ml iodine contrast) did not increase nephropathy. CMR did not increase major adverse cardiac events (5 vs. 8\%, P=0.16) or recurrence of angina (6 vs. 8\%, P=0.73) at 6 months. CMR immediately after PPCI is feasible and safe, allowing very early risk stratification in STEMI.

10.1007/s10554-009-9451-4
Grant Details